欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/4913/003
药品名称ACTAIR 300 IR
活性成分
    • allergen extract mixture 300.0 IR
剂型Sublingual tablet
上市许可持有人Stallergènes 6, rue Alexis de Tocqueville 92160 Antony France
参考成员国 - 产品名称Germany (DE)
ACTAIR
互认成员国 - 产品名称
    • Croatia (HR)
      Orlymyte 300 IR sublingvalne tablete
    • France (FR)
    • Slovenia (SI)
      ACTAIR 300 IR podjezične tablete
    • Netherlands (NL)
      ACTAIR
    • Bulgaria (BG)
    • Belgium (BE)
      Orylmyte 300 IR comprimés sublinguaux
    • Poland (PL)
    • Norway (NO)
      Aitmyte
    • Austria (AT)
      ACTAIR 300 IR Sublingualtabletten
    • Slovakia (SK)
      ACTAIR 300 IR sublingválne tablety
    • Denmark (DK)
      Actair
    • Sweden (SE)
    • Italy (IT)
    • Portugal (PT)
    • United Kingdom (Northern Ireland) (XI)
    • Czechia (CZ)
      Actair
    • Spain (ES)
    • Ireland (IE)
    • Romania (RO)
    • Luxembourg (LU)
许可日期2021/05/28
最近更新日期2024/06/26
药物ATC编码
    • V01AA03 house dust mites
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4：Biological: Other
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase